Drug
Colistimethate Sodium
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hepatic Cytolysis | 33 | 36.0 | 36.8 | signal |
| 2 | Nephropathy Toxic | 24 | 28.7 | 29.2 | signal |
| 3 | Eosinophilia | 36 | 27.5 | 28.1 | signal |
| 4 | Leukocytosis | 35 | 25.8 | 26.4 | signal |
| 5 | Multiple Organ Dysfunction Syndrome | 41 | 19.6 | 20.1 | signal |
| 6 | Rash Maculo-papular | 31 | 18.6 | 19.0 | signal |
| 7 | Septic Shock | 53 | 16.3 | 16.9 | signal |
| 8 | Haemoptysis | 28 | 13.3 | 13.6 | signal |
| 9 | Haematotoxicity | 9 | 12.9 | 13.0 | signal |
| 10 | Acute Respiratory Failure | 18 | 12.5 | 12.7 | signal |
| 11 | Bacteraemia | 11 | 12.4 | 12.5 | signal |
| 12 | Hospitalisation | 131 | 11.4 | 12.4 | signal |
| 13 | Conjunctivitis | 14 | 10.1 | 10.2 | signal |
| 14 | Drug Resistance | 18 | 9.3 | 9.4 | signal |
| 15 | Hyperbilirubinaemia | 7 | 9.0 | 9.1 | signal |
| 16 | Clostridium Difficile Colitis | 7 | 8.8 | 8.8 | signal |
| 17 | Gastric Ulcer | 10 | 7.0 | 7.0 | signal |
| 18 | Multi-organ Failure | 9 | 6.8 | 6.9 | signal |
| 19 | Abnormal Weight Gain | 6 | 6.4 | 6.4 | signal |
| 20 | Hypoaesthesia Oral | 7 | 6.2 | 6.2 | signal |
| 21 | Neurotoxicity | 8 | 6.1 | 6.2 | signal |
| 22 | Erythema Multiforme | 4 | 5.7 | 5.7 | signal |
| 23 | Lymphopenia | 6 | 5.7 | 5.7 | signal |
| 24 | Hepatocellular Injury | 6 | 5.6 | 5.6 | signal |
| 25 | Myoclonus | 5 | 5.6 | 5.6 | signal |
| 26 | Drug Reaction With Eosinophilia And Systemic Symptoms | 10 | 5.2 | 5.2 | signal |
| 27 | Neuroleptic Malignant Syndrome | 4 | 4.5 | 4.5 | signal |
| 28 | Drug Level Increased | 5 | 4.0 | 4.0 | signal |
| 29 | Bone Marrow Failure | 6 | 3.9 | 3.9 | signal |
| 30 | Dialysis | 4 | 3.7 | 3.7 | signal |
| 31 | Agranulocytosis | 5 | 3.6 | 3.6 | signal |
| 32 | Exposure During Pregnancy | 16 | 3.4 | 3.4 | signal |
| 33 | Foetal Exposure During Pregnancy | 15 | 2.5 | 2.5 | signal |